Martin Edwards is Director of Verona Pharma plc. Currently has a direct ownership of 144,800 shares of VRNA, which is worth approximately $5.48 Million. The most recent transaction as insider was on Nov 20, 2023, when has been sold 33,736 shares (Ordinary Shares) at a price of $1.84 per share, resulting in proceeds of $62,074. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K
0% 3M change
0% 12M change
Total Value Held $5.48 Million

Martin Edwards Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2023
BUY
Open market or private purchase
$62,074 $1.84 p/Share
33,736 Added 18.9%
144,800 Ordinary Shares
May 04 2021
SELL
Open market or private sale
$10,100 $0.84 p/Share
12,024 Reduced 9.77%
111,064 Ordinary Shares
Feb 01 2021
SELL
Open market or private sale
$13,551 $0.99 p/Share
13,688 Reduced 10.01%
123,088 Ordinary Shares

Also insider at

RETA
REATA PHARMACEUTICALS INC Healthcare
MORF
Morphic Holding, Inc. Healthcare
KALV
KalVista Pharmaceuticals, Inc. Healthcare
INZY
Inozyme Pharma, Inc. Healthcare
ME

Martin Edwards

Director
Plano, TX

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA